WASHINGTON -(Dow Jones)- A drug by Bristol-Myers Squibb Co. (BMY) used to enhance the diagnosis of heart problems using ultrasound imaging machines will carry a new warning about serious cardiopulmonary reactions and deaths associated with the product.
